Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Moschini

Showing results (311-320 of 561) with videos related to

Pageof 57
Sort By:
Oncotargets and Therapy|January 25, 2021
Further Understanding of Urokinase Plasminogen Activator Overexpression in Urothelial Bladder Cancer Progression, Clinical Outcomes and Potential Therapeutic TargetsNico C Grossmann, Victor M Schuettfort, Benjamin Pradere, et al.
BJU International|April 15, 2024
Use of 18F-fluoro-2-deoxy-d-glucose (18F-FDG) PET/CT for lymph node assessment before radical cystectomy in bladder cancer patientsMattia Longoni, Pietro Scilipoti, Chiara Re, et al.
Clinical Genitourinary Cancer|August 2, 2022
Focal High-Intensity Focused Ultrasound vs. Active Surveillance for ISUP Grade 1 Prostate Cancer: Medium-Term Results of a Matched-Pair ComparisonGiancarlo Marra, Timo Soeterik, Davide Oreggia, et al.
Clinical Genitourinary Cancer|March 10, 2019
Evaluation of Cause of Death After Radical Cystectomy for Patients With Bladder Cancer: The Impact of Age at the Time of SurgeryMarco Moschini, Alberto Martini, Stefania Zamboni, et al.
Frontiers in Immunology|July 31, 2023
Intravesical BCG in bladder cancer induces innate immune responses against SARS-CoV-2Renate Pichler, Gabriel Diem, Hubert Hackl, et al.
European Urology Oncology|July 17, 2019
Efficacy of Surgery in the Primary Tumor Site for Metastatic Urothelial Cancer: Analysis of an International, Multicenter, Multidisciplinary DatabaseMarco Moschini, Evanguelos Xylinas, Stefania Zamboni, et al.
The Prostate|August 7, 2023
Survival outcomes of patients treated with local therapy for nonmetastatic prostate cancer with high prostate-specific antigen concentrationsAleksander Ślusarczyk, Michael Baboudjian, Piotr Zapała, et al.
Journal of Clinical Medicine|June 27, 2024
Perioperative Outcomes and Trends in Transurethral Resection of Bladder Tumors with Photodynamic Diagnosis: Results from the GeRmAn Nationwide Inpatient Data StudyNikolaos Pyrgidis, Marco Moschini, Lazaros Tzelves, et al.
World Journal of Urology|December 5, 2019
Expression of urokinase-type plasminogen activator system in non-metastatic prostate cancerShoji Kimura, David D'Andrea, Takehiro Iwata, et al.
Cancers|September 9, 2022
Online Crowdfunding for Urologic Cancer CarePawel Rajwa, Philip Hopen, Jakub Wojnarowicz, et al.
Pageof 57

Showing results (311-320 of 561) with videos related to

Sort By:
Pageof 57
Oncotargets and Therapy|January 25, 2021
Further Understanding of Urokinase Plasminogen Activator Overexpression in Urothelial Bladder Cancer Progression, Clinical Outcomes and Potential Therapeutic TargetsNico C Grossmann, Victor M Schuettfort, Benjamin Pradere, et al.
BJU International|April 15, 2024
Use of 18F-fluoro-2-deoxy-d-glucose (18F-FDG) PET/CT for lymph node assessment before radical cystectomy in bladder cancer patientsMattia Longoni, Pietro Scilipoti, Chiara Re, et al.
Clinical Genitourinary Cancer|August 2, 2022
Focal High-Intensity Focused Ultrasound vs. Active Surveillance for ISUP Grade 1 Prostate Cancer: Medium-Term Results of a Matched-Pair ComparisonGiancarlo Marra, Timo Soeterik, Davide Oreggia, et al.
Clinical Genitourinary Cancer|March 10, 2019
Evaluation of Cause of Death After Radical Cystectomy for Patients With Bladder Cancer: The Impact of Age at the Time of SurgeryMarco Moschini, Alberto Martini, Stefania Zamboni, et al.
Frontiers in Immunology|July 31, 2023
Intravesical BCG in bladder cancer induces innate immune responses against SARS-CoV-2Renate Pichler, Gabriel Diem, Hubert Hackl, et al.
European Urology Oncology|July 17, 2019
Efficacy of Surgery in the Primary Tumor Site for Metastatic Urothelial Cancer: Analysis of an International, Multicenter, Multidisciplinary DatabaseMarco Moschini, Evanguelos Xylinas, Stefania Zamboni, et al.
The Prostate|August 7, 2023
Survival outcomes of patients treated with local therapy for nonmetastatic prostate cancer with high prostate-specific antigen concentrationsAleksander Ślusarczyk, Michael Baboudjian, Piotr Zapała, et al.
Journal of Clinical Medicine|June 27, 2024
Perioperative Outcomes and Trends in Transurethral Resection of Bladder Tumors with Photodynamic Diagnosis: Results from the GeRmAn Nationwide Inpatient Data StudyNikolaos Pyrgidis, Marco Moschini, Lazaros Tzelves, et al.
World Journal of Urology|December 5, 2019
Expression of urokinase-type plasminogen activator system in non-metastatic prostate cancerShoji Kimura, David D'Andrea, Takehiro Iwata, et al.
Cancers|September 9, 2022
Online Crowdfunding for Urologic Cancer CarePawel Rajwa, Philip Hopen, Jakub Wojnarowicz, et al.
Pageof 57